Cervical Cancer Screening for Medi-Cal and Family PACT Effective May 1, 2013:
Cytology screening begins at 21 years of age, regardless of the age at first intercourse. Screening women younger than 21 for cervical cancer lacks proven benefit and is harmful to some women because of over-diagnosis and over-treatment.
Women 21-30 years of age may have cytology screening every three years and women between 30 and 65 years of age may opt either for cytology every three years or co-testing every five years (co-testing is not a Family PACT benefit).
Women who were DES-exposed in utero should be screened annually.
Women who have been treated for CIN II, III, or adenocarcinoma in situ (AIS) must be regularly screened for 20 years, even if 65 years of age or older, either with cytology every three years or co-testing every five years (co-testing is not a Family PACT benefit).
HPV-DNA testing is limited to reflex testing for clients 21 years of age and older with a cervical cytology result of Atypical Squamous Cells of Undetermined Significance (ASCUS) or Atypical Glandular Cells of Undetermined Significance (AGUS) only.
Tests ordered by physicians that do not meet these guidelines will be billed directly to the patient by the lab.